The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.
News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc. using a superconducting quantum...
News | Atrial Fibrillation | October 06, 2020
October 6, 2020 – The U.S. Food and Drug Administration (FDA) cleared the Biosense Webster ThermoCool SmartTouch SF...
Chest X-ray of a congestive heart failure patient, showing fluid in the lower portions of the lungs and an enlarged heart. Getty Images
News | Heart Failure | October 05, 2020
October 5, 2020 — The American College of Cardiology (ACC) says heart failure (HF) is a cardiovascular epidemic. In...
Sponsored Content
Feature | Wearables | December 15, 2020
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office...
News | VIVA | October 05, 2020
October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical...
Webinar | Cardiovascular Information Systems (CVIS) | October 05, 2020
The dynamics of our world are changing rapidly. Cardiologists are being challenged to complete documentation in an...
Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and very low survival rates. Getty Images
Feature | Coronavirus (COVID-19) | October 02, 2020
October 2, 2020 — Even when a sudden cardiac arrest happens inside a top hospital, where a code blue team is readily...
Sponsored Content
Case Study | Cardiovascular Information Systems (CVIS) | November 23, 2020
This Frost & Sullivan Executive White Paper explains that digitization is the shift to value-based care and risk-...
News | Heart Valve Technology | October 02, 2020
October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be...
Videos | Left Atrial Appendage (LAA) Occluders | October 02, 2020
Horst Sievert, M.D., is the director of the Cardiovascular Center Frankfurt, and associate professor of internal...
The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario, Canada, represents a new frontier in cardiac surgery. The customized OR features a Siemens Artis Pheno angiogray system with 3-D imaging capability with an integrated OR table that together improve workflow, increase efficiency and ensure a high-level of infection control.
News | Hybrid OR | October 02, 2020
October 2, 2020 — The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario...
Sponsored Content
OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.
Feature | ECG | March 11, 2020
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness...
The FDA granted 510(k) clearance for the SentiAR CommandEP system, the first holographic guidance system to be used during an invasive electrophysiology (EP) lab cardiac procedures. The system allows electrophysiologists to visualize 3-D electro-anatomic models in real-time, via a wearable headset and offer a truly handsfree control interface providing superior visualization, allowing them to navigate accurately within the heart during a cardiac ablation procedure.
News | Virtual and Augmented Reality | October 01, 2020
October 1, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the SentiAR CommandEP system...
Videos | EP Lab | October 01, 2020
Peter Weiss M.D., MSc, director of ventricular arrhythmia management and robotics, and assistant clinical professor of...
The FDA has cleared a new indication for the Medtronic Resolute Onyx Drug Eluting Stent, making it the first DES that only required one month of dual antiplatelet therapy (DAPT) in patients who are considered high risk for bleeding complications.
News | Stents | October 01, 2020
October 1, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-...
Sponsored Content
Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.
Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
The researchers developed an ultra thin monolithic OCT endoscope that overcomes the limitations of current, larger OCT catheters by using 3-D printed components.
News | Optical Coherence Tomography (OCT) | October 01, 2020
October 1, 2020 — A team of researchers led by the University of Adelaide and University of Stuttgart has used 3-D...
The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.
Feature | October 01, 2020 | Dave Fornell, Editor
October 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
Videos | EP Lab | September 30, 2020
Peter Weiss M.D., MSc, director of ventricular arrhythmia management and robotics, and assistant clinical professor of...
